143 related articles for article (PubMed ID: 35711848)
21. Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.
Yu D; Jin C; Leja J; Majdalani N; Nilsson B; Eriksson F; Essand M
J Virol; 2011 Dec; 85(24):13114-23. PubMed ID: 21957304
[TBL] [Abstract][Full Text] [Related]
22. New Thyrointegrin α
Hay BA; Godugu K; Darwish NHE; Fujioka K; Sudha T; Karakus OO; Mousa SA
J Med Chem; 2021 May; 64(9):6300-6309. PubMed ID: 33886292
[TBL] [Abstract][Full Text] [Related]
23. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
More SS; Itsara M; Yang X; Geier EG; Tadano MK; Seo Y; Vanbrocklin HF; Weiss WA; Mueller S; Haas-Kogan DA; Dubois SG; Matthay KK; Giacomini KM
Clin Cancer Res; 2011 Apr; 17(8):2339-49. PubMed ID: 21421857
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of
Das S; Sakhare N; Mathur A; Mallia MB; Mirapurkar S; Sheela M; Sarma HD; Sachdev SS; Dash A
Nucl Med Biol; 2019; 68-69():49-57. PubMed ID: 30770228
[TBL] [Abstract][Full Text] [Related]
25. Norepinephrine Transporter as a Target for Imaging and Therapy.
Pandit-Taskar N; Modak S
J Nucl Med; 2017 Sep; 58(Suppl 2):39S-53S. PubMed ID: 28864611
[TBL] [Abstract][Full Text] [Related]
26. Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.
Glinsky GV; Godugu K; Sudha T; Rajabi M; Chittur SV; Hercbergs AA; Mousa SA; Davis PJ
Metabolites; 2022 Apr; 12(4):. PubMed ID: 35448512
[TBL] [Abstract][Full Text] [Related]
27. Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358892
[TBL] [Abstract][Full Text] [Related]
28. Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).
Scherzinger-Laude K; Schönherr C; Lewrick F; Süss R; Francese G; Rössler J
Int J Nanomedicine; 2013; 8():2197-211. PubMed ID: 23818777
[TBL] [Abstract][Full Text] [Related]
29. [
Kobayashi M; Mizutani A; Nishi K; Muranaka Y; Nishii R; Shikano N; Nakanishi T; Tamai I; Kleinerman ES; Kawai K
Nucl Med Biol; 2020; 90-91():49-54. PubMed ID: 33032192
[TBL] [Abstract][Full Text] [Related]
30. Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via α
Urbinati C; Grillo E; Chiodelli P; Tobia C; Caccuri F; Fiorentini S; David G; Rusnati M
Oncogene; 2017 May; 36(18):2609-2618. PubMed ID: 27819680
[TBL] [Abstract][Full Text] [Related]
31. Targeting PI3K in neuroblastoma.
Spitzenberg V; König C; Ulm S; Marone R; Röpke L; Müller JP; Grün M; Bauer R; Rubio I; Wymann MP; Voigt A; Wetzker R
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1881-90. PubMed ID: 20224967
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture.
Darbinian-Sarkissian N; Czernik M; Peruzzi F; Gordon J; Rappaport J; Reiss K; Khalili K; Amini S
J Cell Physiol; 2006 Sep; 208(3):506-15. PubMed ID: 16741963
[TBL] [Abstract][Full Text] [Related]
33. Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium.
Beaudry P; Nilsson M; Rioth M; Prox D; Poon D; Xu L; Zweidler-Mckay P; Ryan A; Folkman J; Ryeom S; Heymach J
Mol Cancer Ther; 2008 Feb; 7(2):418-24. PubMed ID: 18245671
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.
Zhang L; Vines DC; Scollard DA; McKee T; Komal T; Ganguly M; Do T; Wu B; Alexander N; Vali R; Shammas A; Besanger T; Baruchel S
Contrast Media Mol Imaging; 2017; 2017():9481276. PubMed ID: 29097943
[TBL] [Abstract][Full Text] [Related]
35. 8-methoxypsoralen reduces AKT phosphorylation, induces intrinsic and extrinsic apoptotic pathways, and suppresses cell growth of SK-N-AS neuroblastoma and SW620 metastatic colon cancer cells.
Bartnik M; Sławińska-Brych A; Żurek A; Kandefer-Szerszeń M; Zdzisińska B
J Ethnopharmacol; 2017 Jul; 207():19-29. PubMed ID: 28627461
[TBL] [Abstract][Full Text] [Related]
36. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
[TBL] [Abstract][Full Text] [Related]
37. Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.
Ikegaki N; Shimada H; Fox AM; Regan PL; Jacobs JR; Hicks SL; Rappaport EF; Tang XX
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6097-102. PubMed ID: 23479628
[TBL] [Abstract][Full Text] [Related]
38. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
39. Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.
Temple W; Mendelsohn L; Kim GE; Nekritz E; Gustafson WC; Lin L; Giacomini K; Naranjo A; Van Ryn C; Yanik GA; Kreissman SG; Hogarty M; Matthay KK; DuBois SG
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):474-481. PubMed ID: 26338179
[TBL] [Abstract][Full Text] [Related]
40. Syntheses and Preliminary Evaluation of Dual Target PET Probe [18F]-NOTA-Gly3- E (2PEG4-RGD-WH701) for PET Imaging of Breast Cancer.
Chen Z; Fu H; Wu H; Huang J; Yao L; Zhang X; Li Y
Anticancer Agents Med Chem; 2020; 20(13):1548-1557. PubMed ID: 32329699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
